UBQLN1 and epilepsy: In an in vitro epilepsy model, researchers have found that using niacinamide (NM) to increase Ubqln1 expression can stabilize GABAA receptors to relieve the generation of epileptiform activity [46], suggesting that modulating Ubqln1 could be a potential strategy for alleviating the epileptogenesis.